|
28 Companies |
|
20 Products |
|
20 Products |
|
0 Mechanisms of Action |
|
56 Trials |
|
636 News |
|
| «1234567891011» |
- memantine / Generic mfg.
Trial primary completion date: A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM) (clinicaltrials.gov) - Oct 10, 2014
P2, N=60, Recruiting, Sponsor: Evdokia Anagnostou
Trial primary completion date: Aug 2014 --> Aug 2015
- memantine / Generic mfg.
Enrollment change, Trial primary completion date: A Study of Memantine Hydrochloride (Namenda (clinicaltrials.gov) - Oct 10, 2014
P4, N=25, Active, not recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Aug 2014 --> Aug 2015 N=20 --> 25 | Trial primary completion date: Jan 2014 --> Jul 2014
- BAER-101 / AstraZeneca, Fortress
Enrollment open: FAST-AS: Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial (clinicaltrials.gov) - Oct 10, 2014
P2, N=40, Recruiting, Sponsor: University of California, Los Angeles
N=20 --> 25 | Trial primary completion date: Jan 2014 --> Jul 2014 Not yet recruiting --> Recruiting
- | New P4 trial: Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study (clinicaltrials.gov) - Oct 2, 2014
P4, N=25, Recruiting, Sponsor: Seattle Children's Hospital
- Increlex (mecasermin) / Ipsen
Trial primary completion date: Treatment of Rett Syndrome With Recombinant Human IGF-1 (clinicaltrials.gov) - Sep 30, 2014
P2, N=30, Recruiting, Sponsor: Children's Hospital Boston
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2014 --> Dec 2015
- || Enrollment change: Social and Communication Outcomes for Young Children With Autism (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=112, Completed, Sponsor: Health Resources and Services Administration (HRSA)
Trial primary completion date: Dec 2014 --> Dec 2015 N=200 --> 112
- Trial primary completion date: Stem Cell Therapy in Autism Spectrum Disorders (clinicaltrials.gov) - Sep 16, 2014
P1, N=150, Recruiting, Sponsor: Neurogen Brain and Spine Institute
N=200 --> 112 Trial primary completion date: Feb 2014 --> Feb 2015
- Enrollment open: Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD (clinicaltrials.gov) - Sep 16, 2014
P4, N=40, Recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Feb 2014 --> Feb 2015 Not yet recruiting --> Recruiting
- || Enrollment closed: SynapDx Autism Gene Expression Analysis Study (STORY) (clinicaltrials.gov) - Sep 12, 2014
P=N/A, N=880, Active, not recruiting, Sponsor: SynapDx
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment closed: Early Detection of Autism Spectrum Disorder in Children (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=50, Active, not recruiting, Sponsor: St. Louis University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | New P4 trial: Multisite Study: Parental Training Using Video Modelling to Develop Social Skills in Children With Autism (clinicaltrials.gov) - Sep 10, 2014
P4, N=67, Active, not recruiting, Sponsor: Federal University of S
- baclofen / Generic mfg.
Trial initiation date, Trial primary completion date: Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen (clinicaltrials.gov) - Sep 9, 2014
P=N/A, N=5, Recruiting, Sponsor: University of Missouri-Columbia
Recruiting --> Active, not recruiting Initiation date: May 2011 --> Sep 2014 | Trial primary completion date: Jun 2013 --> Jun 2017
- Enrollment open: Brain Imaging of Intranasal Oxytocin Treatment in Autism (clinicaltrials.gov) - Sep 4, 2014
P1, N=28, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Initiation date: May 2011 --> Sep 2014 | Trial primary completion date: Jun 2013 --> Jun 2017 Not yet recruiting --> Recruiting
- leucovorin calcium / Generic mfg.
Enrollment change: A Folinic Acid Intervention for Autism Spectrum Disorders (clinicaltrials.gov) - Aug 29, 2014
P2, N=192, Recruiting, Sponsor: University of Arkansas
Not yet recruiting --> Recruiting N=144 --> 192
- || balovaptan (RG7314) / Roche
Trial primary completion date: VANILLA: A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) (clinicaltrials.gov) - Aug 21, 2014
P2, N=130, Recruiting, Sponsor: Hoffmann-La Roche
N=144 --> 192 Trial primary completion date: Mar 2015 --> Aug 2015
- ||| Clinical: An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD) (clinicaltrials.gov) - Aug 21, 2014
P=N/A, N=51, Recruiting, Sponsor: Enzymotec
- || New P2/3 trial: Cortical Metrics in Intervention Trials With Autism Spectrum Disorders (clinicaltrials.gov) - Aug 8, 2014
P2/3, N=60, Recruiting, Sponsor: University of North Carolina, Chapel Hill
- Trial initiation date, Trial primary completion date: Brain Imaging of Intranasal Oxytocin Treatment in Autism (clinicaltrials.gov) - Jul 30, 2014
P1, N=28, Not yet recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Mar 2015 --> Aug 2015 Initiation date: Feb 2014 --> Sep 2014 | Trial primary completion date: Feb 2015 --> Feb 2018
- Clinical: T-ABA Group Based Early Intervention For Parents of Children With ASD (clinicaltrials.gov) - Jul 30, 2014
P=N/A, N=36, Not yet recruiting, Sponsor: The Cleveland Clinic
- Clinical: National Study on Autism Spectrum Disorder in China (clinicaltrials.gov) - Jul 26, 2014
P=N/A, N=120000, Active, not recruiting, Sponsor: Fudan University
- Enrollment open, Trial initiation date, Trial primary completion date: Using Video Modeled Social Stories to Improve Oral Hygiene in Children With Autism Spectrum Disorder (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=40, Recruiting, Sponsor: Yale University
Initiation date: Feb 2014 --> Sep 2014 | Trial primary completion date: Feb 2015 --> Feb 2018 Not yet recruiting --> Recruiting | Initiation date: Feb 2014 --> Jul 2014 | Trial primary completion date: May 2014 --> Sep 2014
- Clinical: The Effects of a Clean Room Sleeping Environment on Elemental and Chemical Concentrations in Children With Autism (clinicaltrials.gov) - Jul 21, 2014
P=N/A, N=10, Completed, Sponsor: The Children's Institute
- Trial primary completion date: Parenting a Child With Autism Spectrum Disorder and Marital Status (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=200, Recruiting, Sponsor: Sheba Medical Center
Not yet recruiting --> Recruiting | Initiation date: Feb 2014 --> Jul 2014 | Trial primary completion date: May 2014 --> Sep 2014 Trial primary completion date: Oct 2013 --> Jan 2015
- | New P1/2 trial: Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism (clinicaltrials.gov) - Jul 17, 2014
P1/2, N=20, Recruiting, Sponsor: Translational Biosciences
- atomoxetine / Generic mfg.
Trial primary completion date: Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism (clinicaltrials.gov) - Jul 15, 2014
P3, N=86, Recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Oct 2013 --> Jan 2015 Trial primary completion date: Mar 2014 --> Oct 2015
- leucovorin calcium / Generic mfg.
Trial primary completion date: A Folinic Acid Intervention for Autism Spectrum Disorders (clinicaltrials.gov) - Jul 1, 2014
P2, N=144, Recruiting, Sponsor: University of Arkansas
Trial primary completion date: Mar 2014 --> Oct 2015 Trial primary completion date: Sep 2014 --> Sep 2015
- Trial primary completion date: Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents (clinicaltrials.gov) - Jul 1, 2014
P1/2, N=33, Completed, Sponsor: University of South Florida
Trial primary completion date: Sep 2014 --> Sep 2015 Trial primary completion date: Dec 2013 --> Apr 2014
- Enrollment change: Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents (clinicaltrials.gov) - Jul 1, 2014
P1/2, N=33, Completed, Sponsor: University of South Florida
Trial primary completion date: Dec 2013 --> Apr 2014 N=52 --> 33
- Trial completion, Enrollment change, Trial primary completion date: Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents (clinicaltrials.gov) - Jul 1, 2014
P1/2, N=33, Completed, Sponsor: University of South Florida
N=52 --> 33 Active, not recruiting --> Completed | N=52 --> 33 | Trial primary completion date: Dec 2013 --> Apr 2014
- Trial completion: Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG) (clinicaltrials.gov) - Jun 22, 2014
P2, N=38, Completed, Sponsor: Evdokia Anagnostou
Active, not recruiting --> Completed | N=52 --> 33 | Trial primary completion date: Dec 2013 --> Apr 2014 Active, not recruiting --> Completed
- Trial primary completion date: Hyperthermia and the Amelioration of Autism Symptoms (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=15, Completed, Sponsor: Montefiore Medical Center
Active, not recruiting --> Completed Trial primary completion date: Jul 2013 --> Nov 2013
- Enrollment open: INOXT: INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders (clinicaltrials.gov) - Jun 19, 2014
P2, N=146, Recruiting, Sponsor: Evdokia Anagnostou
Trial primary completion date: Jul 2013 --> Nov 2013 Not yet recruiting --> Recruiting
- Trial completion, Trial primary completion date: Hyperthermia and the Amelioration of Autism Symptoms (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=15, Completed, Sponsor: Montefiore Medical Center
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Jul 2013 --> Nov 2013
- trichuris suis ova (CNDO-201) / Fortress
Trial primary completion date: TSO: Trichuris Suis Ova in Autism Spectrum Disorders (clinicaltrials.gov) - Jun 13, 2014
P1, N=10, Active, not recruiting, Sponsor: Montefiore Medical Center
Recruiting --> Completed | Trial primary completion date: Jul 2013 --> Nov 2013 Trial primary completion date: Dec 2013 --> Jun 2014
- trichuris suis ova (CNDO-201) / Fortress
Enrollment closed, Trial primary completion date: TSO: Trichuris Suis Ova in Autism Spectrum Disorders (clinicaltrials.gov) - Jun 13, 2014
P1, N=10, Active, not recruiting, Sponsor: Montefiore Medical Center
Trial primary completion date: Dec 2013 --> Jun 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2014
- Clinical: Effects of a Task Oriented Intervention With Two Goal-setting Approaches (clinicaltrials.gov) - Jun 12, 2014
P=N/A, N=34, Completed, Sponsor: Gävleborg County Council, Sweden
- |||| Trial completion: Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) (clinicaltrials.gov) - Jun 4, 2014
P2, N=748, Completed, Sponsor: Forest Laboratories
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2014 Active, not recruiting --> Completed
- |||| aripiprazole / Generic mfg.
Trial primary completion date: Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders (clinicaltrials.gov) - Jun 2, 2014
P3, N=60, Recruiting, Sponsor: Indiana University
Active, not recruiting --> Completed Trial primary completion date: Mar 2014 --> Mar 2015
- Clinical: Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders (clinicaltrials.gov) - May 29, 2014
P=N/A, N=40, Not yet recruiting, Sponsor: Université de Montréal
- Clinical: SSD_ASD: Social Skills in Children With Autism Spectrum Disorders (clinicaltrials.gov) - May 22, 2014
P=N/A, N=44, Completed, Sponsor: Yale University
- | trichuris suis ova (CNDO-201) / Fortress
New P2a trial: Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder (clinicaltrials.gov) - May 14, 2014
P2a, N=20, Recruiting, Sponsor: Coronado Biosciences, Inc.
- Clinical: Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders (clinicaltrials.gov) - May 13, 2014
P=N/A, N=40, Recruiting, Sponsor: Yale University
- Trial initiation date: INOXT: INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders (clinicaltrials.gov) - Apr 27, 2014
P2, N=146, Not yet recruiting, Sponsor: Evdokia Anagnostou
Trial primary completion date: Mar 2014 --> Mar 2015 Initiation date: Mar 2014 --> May 2014
- trichuris suis ova (CNDO-201) / Fortress
Trial initiation date: TSO in Pediatric Autistic Spectrum Disorders (clinicaltrials.gov) - Apr 15, 2014
P2, N=60, Recruiting, Sponsor: Hadassah Medical Organization
Initiation date: Mar 2014 --> May 2014 Initiation date: Jun 2013 --> Apr 2014
- trichuris suis ova (CNDO-201) / Fortress
Enrollment open: TSO in Pediatric Autistic Spectrum Disorders (clinicaltrials.gov) - Apr 15, 2014
P2, N=60, Recruiting, Sponsor: Hadassah Medical Organization
Initiation date: Jun 2013 --> Apr 2014 Not yet recruiting --> Recruiting
- Enrollment change: A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=28, Completed, Sponsor: Newport Brain Research Laboratory
Not yet recruiting --> Recruiting N=36 --> 28
- | Trial completion: A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=28, Completed, Sponsor: Newport Brain Research Laboratory
N=36 --> 28 Recruiting --> Completed
- | Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
Trial completion: Assessment of the Pharmacokinetics of Circadin (clinicaltrials.gov) - Apr 2, 2014
P1, N=16, Completed, Sponsor: Neurim Pharmaceuticals Ltd.
Recruiting --> Completed Recruiting --> Completed
- New P4 trial: Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD (clinicaltrials.gov) - Mar 24, 2014
P4, N=40, Not yet recruiting, Sponsor: Massachusetts General Hospital
- memantine / Generic mfg.
Enrollment closed: A Study of Memantine Hydrochloride (Namenda (clinicaltrials.gov) - Mar 23, 2014
P4, N=20, Active, not recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Recruiting --> Active, not recruiting